ARIG inhibition improves the prognosis of liver cancer through autophagy regulation and tumor immunity enhancement

您当前的位置：

首页 >

文章列表页 >

Short communication | 更新时间：2023-08-29

- ARIG inhibition improves the prognosis of liver cancer through autophagy regulation and tumor immunity enhancement
- Genes & Diseases Vol. 10, Issue 5, (2023)
- 作者机构：
  
  1. Department of Hepatobiliary and Pancreatic Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,Zhejiang,Jinhua,China,321000
  2. Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine,Zhejiang,Hangzhou,China,310009
  3. Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Clinical Research Center for Oral Diseases of Zhejiang Province, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University,Zhejiang,Hangzhou,China,310006
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2022.10.007
  CLC：
- Published：2023，
  
  Published Online：1 September 2023，
扫描看全文
Jiaqi Chen, Xiaoting Zhang, Weijian Hu, et al. ARIG inhibition improves the prognosis of liver cancer through autophagy regulation and tumor immunity enhancement. [J]. Genes & Diseases 10(5).(2023)
DOI：

Jiaqi Chen, Xiaoting Zhang, Weijian Hu, et al. ARIG inhibition improves the prognosis of liver cancer through autophagy regulation and tumor immunity enhancement. [J]. Genes & Diseases 10(5).(2023) DOI： 10.1016/j.gendis.2022.10.007.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰